NIH-funded research R01 grant

Game Changers to help women promote cervical cancer screening in Uganda

Official title: A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda

Funded at Rand Corporation · NIH-11404687 · Data updated 2026-11-12

A peer-led program trains women who were screened to encourage friends and family to get cervical cancer screening in Uganda.

More Cervical Cancer research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionRand Corporation
NIH-funded
Lab location1 site (Santa Monica, United States)
Project startAugust 8, 2023
Project endJuly 31, 2028
Funding year2025
Award (this year)$16,796
NIH project number3R01CA282284-03S2
Project IDNIH-11404687 on NIH RePORTER

Who could benefit from this research

Could help

Women in Uganda who are eligible for cervical cancer screening or women who have recently been screened and want to serve as peer leaders are ideal candidates.

Less likely to help

People who do not live in participating Ugandan communities, men, or women who already get regular screening are unlikely to benefit directly from joining this program.

What this research studies

You would be part of a community program where women who recently had cervical screening lead seven group sessions to share knowledge, dispel myths, and reduce stigma about screening. Those trained peers are supported to talk with women in their social networks and encourage them to get visual inspection with acetic acid (VIA) screening. The research team will compare communities where the program is offered to others to see whether more women get screened and whether the approach can be kept going over time. The work builds on a small pilot that showed much higher screening among people reached through peers.

Why it matters

Potential benefit: If successful, the program could increase screening so more cancers are caught earlier and fewer women present with advanced disease.

How similar studies have gone: A prior pilot randomized trial funded by an R21 showed dramatic increases in screening among social network members reached by the peer-led intervention.

Where this research is happening

  • Rand Corporation
    Santa Monica, United States
    Active

Researchers

  • Principal investigator: Wagner, Glenn John — Rand Corporation
  • Study coordinator: Wagner, Glenn John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.